Non-small cell lung carcinomas
MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3
9
Original Article Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas
9
Positive nuclear BAP1 immunostaining helps differentiate non- small cell lung carcinomas from malignant mesothelioma
8
Relationship of the K-ras/c-mos Expression Patterns With Angiogenesis in Non-Small Cell Lung Carcinomas
8
Low Levels of p27 in Association With Deregulated p53-pRb Protein Status Enhance Tumor Proliferation and Chromosomal Instability in Non-Small Cell Lung Carcinomas
12
Evaluation of Epidermal Growth Factor Receptor by Mutation Specific Immunohistochemistry in Non Small Cell Lung Carcinomas
124
Original Article Downregulation of ALDH1A1 expression in non-small cell lung carcinomas – its clinicopathologic and biological significance
12
CD10/NEP in non small cell lung carcinomas Relationship to cellular proliferation
9
Genome-wide DNA methylation profiling of non-small cell lung carcinomas
18
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas
7
Case Report Parotid gland and cerebellum metastasis of lung cancer: a case report
7
Lung cancer cytology: potential pitfalls- a review
6
Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin
7
Prognostic Role of miR 205 in Early Stage (T1N0) Non Small Cell Lung Cancer
8
Original Article Downregulation of TMEM176A suppresses cell growth and proliferationin non-small cell lung cancer
9
Prognostic value of angiopoietin 2 in non small cell lung cancer patients: a meta analysis
9
Vaccines in Non Small Cell Lung Cancer
6
Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
5
Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report
6
FDG PET in the evaluation of response to nivolumab in recurrent non small cell lung cancer
5